Literature DB >> 16779643

Transgenic RNAi: Accelerating and expanding reverse genetics in mammals.

Xu-Gang Xia1, Hongxia Zhou, Zuoshang Xu.   

Abstract

Reverse genetics in mammals has relied on gene targeting strategies and has mostly been limited to the mouse. Gene targeting through homologous recombination in mouse ES cells has drawbacks which include time, expense and complexity. Recently, a new approach has been developed based on RNA-interference (RNAi) which is simpler, faster, less expensive, and should be applicable to mammalian species other than mouse. The advent of RNAi is poised to accelerate the pace at which reverse genetics can be applied to study gene function in mammals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16779643     DOI: 10.1007/s11248-006-0023-2

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  37 in total

1.  Specific interference with gene function by double-stranded RNA in early mouse development.

Authors:  F Wianny; M Zernicka-Goetz
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

Review 2.  Transcription and processing of human microRNA precursors.

Authors:  Bryan R Cullen
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

Review 3.  MicroRNA biogenesis: coordinated cropping and dicing.

Authors:  V Narry Kim
Journal:  Nat Rev Mol Cell Biol       Date:  2005-05       Impact factor: 94.444

4.  Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis.

Authors:  Manjeet K Rao; John Pham; J Saadi Imam; James A MacLean; Deepa Murali; Yasuhide Furuta; Amiya P Sinha-Hikim; Miles F Wilkinson
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

5.  Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype.

Authors:  Tilo Kunath; Gerald Gish; Heiko Lickert; Nina Jones; Tony Pawson; Janet Rossant
Journal:  Nat Biotechnol       Date:  2003-04-07       Impact factor: 54.908

Review 6.  Promises and challenges in developing RNAi as a research tool and therapy for neurodegenerative diseases.

Authors:  Xu Gang Xia; Hongxia Zhou; Zuoshang Xu
Journal:  Neurodegener Dis       Date:  2005       Impact factor: 2.977

7.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.

Authors:  Douglas A Rubinson; Christopher P Dillon; Adam V Kwiatkowski; Claudia Sievers; Lili Yang; Johnny Kopinja; Dina L Rooney; Mingdi Zhang; Melanie M Ihrig; Michael T McManus; Frank B Gertler; Martin L Scott; Luk Van Parijs
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

8.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

9.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

10.  A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.

Authors:  Gustavo Tiscornia; Oded Singer; Masahito Ikawa; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more
  5 in total

1.  Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis.

Authors:  Huizhen Wang; T Rajendra Kumar
Journal:  Gene Expr Patterns       Date:  2012-01-24       Impact factor: 1.224

Review 2.  Use of intracytoplasmic sperm injection (ICSI) to generate transgenic animals.

Authors:  Stefan Moisyadi; Joseph M Kaminski; Ryuzo Yanagimachi
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2008-08-08       Impact factor: 2.268

3.  Immunization against proprotein convertase subtilisin-like/kexin type 9 lowers plasma LDL-cholesterol levels in mice.

Authors:  Elena Fattori; Manuela Cappelletti; Paola Lo Surdo; Alessandra Calzetta; Claus Bendtsen; Yan G Ni; Shilpa Pandit; Ayesha Sitlani; Giuseppe Mesiti; Andrea Carfí; Paolo Monaci
Journal:  J Lipid Res       Date:  2012-05-19       Impact factor: 5.922

4.  Hepatic stellate cell-specific gene silencing induced by an artificial microRNA for antifibrosis in vitro.

Authors:  Ying Chang; Hua-jun Jiang; Xue-mei Sun; Xiao-kun Cai; Xing-xing He; Pei-yuan Li; Wang-xian Tang; Yu-hu Song; Ju-sheng Lin
Journal:  Dig Dis Sci       Date:  2009-11-05       Impact factor: 3.199

5.  Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice.

Authors:  Hongxia Zhou; Björn H Falkenburger; Jörg B Schulz; Kim Tieu; Zuoshang Xu; Xu Gang Xia
Journal:  Int J Biol Sci       Date:  2007-03-05       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.